The weak AUD has also come at the right time for FMG. The standard AUD rate used by FMG in its forecasts is 0.75. With the dollar hovering in the 71s, eliwana’s capex of US1.28b would be slightly less using a lower AUD rate (some would be direct USD outlays but much of the capex would be wages in AUD) Of course this assumes a low AUD during the duration of the capex period.
Also, investing cash outflows this FY is expected to be USD1.2b. Delivery and payment of the final carrier would likely be in USD but once again the lower AUD would require less USD for a fixed amount of AUD for majority of investing/sustaining capital expenditure incurred.
Cost of sales (c1) last year was USD 2.1b. Much of this would be AUD costs converted back to usd. The AUD averaged around 0.77 in fy18. Given the AUD has averaged around 7% less and oil well below last years avg also, cost of sales in USD this FY may conservatively be up to USD 100m less.
Overall, the above in conjunction with strong cash margins will continue to keep debt and gearing levels low.
![]()
- Forums
- ASX - By Stock
- FMG
- Iron ore price
Iron ore price, page-9135
-
- There are more pages in this discussion • 44,583 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FMG (ASX) to my watchlist
|
|||||
Last
$18.16 |
Change
-0.080(0.44%) |
Mkt cap ! $55.91B |
Open | High | Low | Value | Volume |
$18.43 | $18.45 | $18.16 | $96.94M | 5.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 7669 | $18.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.17 | 2500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 7669 | 18.160 |
12 | 18921 | 18.150 |
3 | 16993 | 18.140 |
5 | 57970 | 18.130 |
7 | 18023 | 18.120 |
Price($) | Vol. | No. |
---|---|---|
18.170 | 2500 | 1 |
18.190 | 5000 | 1 |
18.230 | 5820 | 2 |
18.240 | 3516 | 2 |
18.250 | 2728 | 2 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
FMG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online